PMID,Title,Journal,Year
40652432,Impact of SGLT2i on bone health in patients with lupus nephritis: randomized double blinded placebo-controlled clinical trial.,Journal of nephrology,2025
39810714,"Dapagliflozin combined with metformin improves blood glucose, bone metabolism and bone mineral density in elderly patients with type 2 diabetes mellitus complicated with osteoporosis.",The Kaohsiung journal of medical sciences,2025
37680820,Comparison of the effect of Dapagliflozin and Pioglitazone on the risk of osteoporosis in postmenopausal women with Type-2 diabetes.,Pakistan journal of medical sciences,2023
36589840,Canagliflozin promotes osteoblastic MC3T3-E1 differentiation via AMPK/RUNX2 and improves bone microarchitecture in type 2 diabetic mice.,Frontiers in endocrinology,2022
33013683,Corrigendum: Dapagliflozin Attenuates Hyperglycemia Related Osteoporosis in ZDF Rats by Alleviating Hypercalciuria.,Frontiers in endocrinology,2020
32710428,Diabetes and Bone Fragility: SGLT2 Inhibitor Use in the Context of Renal and Cardiovascular Benefits.,Current osteoporosis reports,2020
31781028,Dapagliflozin Attenuates Hyperglycemia Related Osteoporosis in ZDF Rats by Alleviating Hypercalciuria.,Frontiers in endocrinology,2019
24716752,Empagliflozin for the treatment of Type 2 diabetes.,Expert review of clinical pharmacology,2014
22651373,Dapagliflozin has no effect on markers of bone formation and resorption or bone mineral density in patients with inadequately controlled type 2 diabetes mellitus on metformin.,"Diabetes, obesity & metabolism",2012
